These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21450976)
1. In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei. Zhang S; Feng SH; Li B; Kim HY; Rodriguez J; Tsai S; Lo SC Clin Vaccine Immunol; 2011 May; 18(5):825-34. PubMed ID: 21450976 [TBL] [Abstract][Full Text] [Related]
2. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs. Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541 [TBL] [Abstract][Full Text] [Related]
3. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei. Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353 [TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]
6. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system. Kim HY; Tsai S; Lo SC; Wear DJ; Izadjoo MJ PLoS One; 2011 May; 6(5):e19867. PubMed ID: 21573027 [TBL] [Abstract][Full Text] [Related]
8. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei. Zou N; Newsome T; Li B; Tsai S; Lo SC Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491 [TBL] [Abstract][Full Text] [Related]
9. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related]
10. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei. Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015 [TBL] [Abstract][Full Text] [Related]
11. Developing Peptide Mimotopes of Capsular Polysaccharides and Lipopolysaccharides Protective Antigens of Pathogenic Burkholderia Bacteria. Guo P; Zhang J; Tsai S; Li B; Lo SC Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):125-34. PubMed ID: 27328059 [TBL] [Abstract][Full Text] [Related]
12. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938 [TBL] [Abstract][Full Text] [Related]
14. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis. Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei. Duval BD; Elrod MG; Gee JE; Chantratita N; Tandhavanant S; Limmathurotsakul D; Hoffmaster AR Am J Trop Med Hyg; 2014 Jun; 90(6):1043-6. PubMed ID: 24710616 [TBL] [Abstract][Full Text] [Related]
16. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei. Anuntagool N; Sirisinha S Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis. Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423 [TBL] [Abstract][Full Text] [Related]
18. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies. Parthasarathy N; DeShazer D; England M; Waag DM Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554 [TBL] [Abstract][Full Text] [Related]
19. Development of Burkholderia mallei and pseudomallei vaccines. Silva EB; Dow SW Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691 [TBL] [Abstract][Full Text] [Related]